Hytracin en es it fr

Hytracin Brand names, Hytracin Analogs

Hytracin Brand Names Mixture

  • No information avaliable

Hytracin Chemical_Formula


Hytracin RX_link


Hytracin fda sheet

Hytracin FDA

Hytracin msds (material safety sheet)

Hytracin Synthesis Reference

M. Winn et al., U.S. Pat. 4,026,894 (1977)

Hytracin Molecular Weight

387.433 g/mol

Hytracin Melting Point

273 oC

Hytracin H2O Solubility


Hytracin State


Hytracin LogP


Hytracin Dosage Forms


Hytracin Indication

For the treatment of symptomatic benign prostatic hyperplasia (BPH) and also for hypertension.

Hytracin Pharmacology

Terazosin, classified as a quinazoline, is similar to doxazosin and prazosin. As an alpha-adrenergic blocking agent, terazosin is used to treat hypertension and benign prostatic hypertrophy (BPH). Terazosin produces vasodilation and reduces peripheral resistance but in general has slight effect on cardiac output. Antihypertensive effect with chronic dosing is usually not accompanied by reflex tachycardia.

Hytracin Absorption

Essentially completely absorbed in man (90% bioavailability).

Hytracin side effects and Toxicity

LD50=259.3mg/kg (i.v. in mice)

Hytracin Patient Information

Hytracin Organisms Affected

Humans and other mammals